CLEX Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cumulex N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.54 |
| 52 Week High | €1.78 |
| 52 Week Low | €0.54 |
| Beta | -0.80 |
| 1 Month Change | -60.00% |
| 3 Month Change | -33.33% |
| 1 Year Change | -67.27% |
| 3 Year Change | -84.30% |
| 5 Year Change | 3.83% |
| Change since IPO | -92.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLEX | BE Food | BE Market | |
|---|---|---|---|
| 7D | 0% | -2.0% | -1.6% |
| 1Y | -67.3% | 25.9% | 1.2% |
Return vs Industry: CLEX underperformed the Belgian Food industry which returned 25.4% over the past year.
Return vs Market: CLEX underperformed the Belgian Market which returned 1.6% over the past year.
Price Volatility
| CLEX volatility | |
|---|---|
| CLEX Average Weekly Movement | 18.0% |
| Food Industry Average Movement | 3.1% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in BE Market | 6.6% |
| 10% least volatile stocks in BE Market | 2.2% |
Stable Share Price: CLEX's share price has been volatile over the past 3 months compared to the Belgian market.
Volatility Over Time: CLEX's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Belgian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | n/a | Gerben Hettinga | www.cumulex.be |
Cumulex N.V. does not have significant operations. Previously, the company was engaged in sugar plantation business in the Democratic Republic of Congo. The company was formerly known as Sucrerie et Raffinerie de l'Afrique Centrale NV and changed its name to Cumulex N.V. in March 2021.
Cumulex N.V. Fundamentals Summary
| CLEX fundamental statistics | |
|---|---|
| Market cap | €237.60k |
| Earnings (TTM) | -€63.30k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.8x
P/E RatioIs CLEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLEX income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €63.41k |
| Gross Profit | -€63.41k |
| Other Expenses | -€112.00 |
| Earnings | -€63.30k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did CLEX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 12:25 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cumulex N.V. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|